Immuno-Oncology News

June 27, 2017June 27, 2017

83% of Young Leukemia Patients Treated with CTL019 Achieve Remission, and It Lasts, Update Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The leukemia of 83 percent of young patients ... Read more

June 26, 2017June 26, 2017

Cash-strapped ImmunoCellular Reviews ICT-107 Status, Suspends Phase 3 Trial for Glioblastoma

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site ImmunoCellular Therapeutics has suspended further patient randomization in ... Read more

June 23, 2017June 23, 2017

Ilixadencel Provokes Strong Response Against Kidney Cancer, Phase 1/2 Clinical Trial Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Injecting ilixadencel into the tumors of newly diagnosed ... Read more

June 22, 2017June 22, 2017

Generon’s A-337 Antibody Is Entering Phase 1 Trial as Treatment for Solid Tumors

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The A-337 antibody that Generon Corporation developed to sic immune-system ... Read more

June 21, 2017June 21, 2017

Acceleron Discontinues Development of Dalantercept for Advanced Renal Cell Carcinoma Therapy

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The DART Phase 2 clinical trial, assessing Acceleron Pharma’s ... Read more

June 20, 2017June 20, 2017

Radiotherapy Booster NBTXR3 Can Trigger Anti-Tumor Immune Responses, Studies Suggest

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Nanobiotix’s NBTXR3, a compound designed to increase the ... Read more

June 19, 2017June 19, 2017

Trial of Tivozanib as Combo Therapy for Kidney Cancer Enters Phase 2 Stage

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A Phase 1/2 clinical trial assessing a combination ... Read more

June 16, 2017June 18, 2017

Varlilumab-Opdivo Combo Stabilizes or Shrinks Tumors in 80% of Solid-cancer Patients, Trial Shows

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site A combination of varlilumab and Opdivo (nivolumab) stopped tumor growth ... Read more

June 15, 2017June 18, 2017

First Patient Dosed in Immunotherapy Combo Trial of Yervoy, Evofosfamide in Solid Tumors

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site The first patient has been dosed in a ... Read more

June 14, 2017June 18, 2017

Early Trial Data Supports Keytruda as Standalone Therapy for Advanced Stomach Cancers

Immuno-Oncology News

This post was originally published on this siteThis post was originally published on this site Results from a first group of patients in ... Read more